These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation. Pershing LK Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461 [TBL] [Abstract][Full Text] [Related]
8. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations. Gibson JR; Kirsch J; Darley CR; Burke CA Br J Dermatol; 1983 Jul; 109 Suppl 25():114-6. PubMed ID: 6860578 [TBL] [Abstract][Full Text] [Related]
9. Human test models for bioequivalence of topical corticosteroids: a review. Olsen EA Int J Dermatol; 1992 Oct; 31 Suppl 1():9-13. PubMed ID: 1428469 [TBL] [Abstract][Full Text] [Related]
10. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations. Gibson JR; Kirsch JM; Darley CR; Harvey SG; Burke CA; Hanson ME Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245 [TBL] [Abstract][Full Text] [Related]
11. Are generic formulations equivalent to trade name topical glucocorticoids? Stoughton RB Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563 [TBL] [Abstract][Full Text] [Related]
12. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation. Schalla W; Schorning S Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431 [TBL] [Abstract][Full Text] [Related]
13. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids. Poulsen BJ; Burdick K; Bessler S Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938 [No Abstract] [Full Text] [Related]
14. Various vagaries of vasoconstriction. Burdick KH Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376 [No Abstract] [Full Text] [Related]
15. Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital imaging analysis. Smith EW; Haigh JM; Surber C Dermatology; 2002; 205(1):3-10. PubMed ID: 12145427 [TBL] [Abstract][Full Text] [Related]
16. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers. Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237 [TBL] [Abstract][Full Text] [Related]
17. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)]. Zaun H; Altmeyer P Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633 [No Abstract] [Full Text] [Related]
18. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations. Feldman SR; Yentzer BA Am J Clin Dermatol; 2009; 10(6):397-406. PubMed ID: 19824740 [TBL] [Abstract][Full Text] [Related]
19. Clinical use of topical cortisteroids. Sneddon IB Drugs; 1976; 11(3):193-9. PubMed ID: 776579 [TBL] [Abstract][Full Text] [Related]
20. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. Olsen EA Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]